Aduro Biotech Europe Overview
- Founded
-
2011
- Status
-
Acquired/Merged
- Employees
-
23
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$64.6M
Aduro Biotech Europe General Information
Description
Provider of therapeutic services for cancer. The company specializes in the development of oncology antibodies for the treatment of cancer.
Contact Information
Website
www.bionovion.com
Formerly Known As
BioNovion
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Other Healthcare Services
Other Industries
Other Pharmaceuticals and Biotechnology
Drug Discovery
Acquirer
Primary Office
- Pivot Park, RX1101
- Molenweg 79
- 5349 AC OSS
- Netherlands
Aduro Biotech Europe Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Merger/Acquisition | 30-Oct-2015 | $64.6M | 000.00 | Completed | Generating Revenue | |
| 1. Early Stage VC | Completed | Startup |
Aduro Biotech Europe Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Hans Van Eenennaam Ph.D | Co-Founder & Chief Operational Officer | ||
| Andrea Van Elsas Ph.D | Co-Founder & Chief Scientific Officer |
Aduro Biotech Europe Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Aduro Biotech Europe Former Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Agri Food Health Innovation Centre | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Brabant Life Sciences Seed Fund | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Brabantse Ontwikkelings Maatschappij | Growth/Expansion | Minority | 000 0000 | 000000 0 |